Kerttu Inkeroinen is Marketing Director of Lucky Saint, the UK’s #1 dedicated alcohol-free beer brand and a certified B Corporation on a mission to reward those who are no drinking with the beer they deserve.
Kerttu has worked in consumer goods for over 15 years, starting her career working with household-name brands of Kimberly-Clark (Kleenex, Andres and Huggies) before moving on to journey through drinks sector: from the FMCG giant The Coca-Cola Company leaping into the world of scale up at Union Hand-Roasted Coffee, UK’s leading ethical speciality coffee roaster, leading the brand’s repositioning and launch into consumer markets, before joining Lucky Saint in 2022. Having been a fan of the brand already, Kerttu was inspired by the vision and energy of Emma Heal and Luke Boase, Lucky Saint founder, to join them on a mission to build the world’s defining alcohol free brand.
Kerttu is an avid lover of nature, spending time hiking, cycling, trail running and skiing, and passionate about building sustainable, mission-led businesses
Mihad is a Product Director for research and life sciences at EMIS. He has spent the last 10 years leading the dvelopment of data driven products for the clinical trials sector. Working with leading academic and commercial research organisations, he managed the development of a suite of data driven products on the EMIS-X Analytics platform. Prior to joining EMIS, he played a pivotal role in developing various modules within the Medidata Clinical Trial Management System (CTMS) catering to global study teams and sites.
Julie Collard is the Economic Affairs and Events Manager at Eucolait, the European Dairy Trade Association based in Brussels. As the organisation’s market analyst since 2019, Julie is responsible for all data analysis, market reporting and creation of content for Eucolait’s presentations. Her analysis covers the whole dairy supply chain from production to consumption, with a focus on global dairy trade dynamics. She also represents Eucolait in the European Milk Market Observatory expert group. Julie joined the association 15 years ago and was in charge of processing statistics, event management and office administration in her previous role.
Niall English as a professor in Chemical Engineering at University College Dublin, as well as an inventor, chartered chemical engineer a spin-out/start-up entrepreneur. Many of his interests lie in how external fields affect the ordering and behaviour of systems at the nanoscale – such as those composed of water, water-gas and proteins. In particular, he is fascinated how protein assemblies respond to fields – and typically in industrial situations, such a milk processing.
Aqua-B’s disruptive innovation in low-energy, ultra-dense nanobubble (UD-NB) generation in water, and other solvents, stems from its breakthrough discovery of electrostriction-based nano-phase generation. Without any moving parts, these solid-state nanobubble generators can be deployed and retro-fitted for ultra-efficient performance – even Off-Grid (e.g., solar means) to revolutionise water aeration, e.g., for activated-sludge and dissolved-air flotation – slashing OPEX.
Federica Martini is a regulatory professional with 10+ years of experience in the pharmaceutical and biotech industry and brings an extensive background in cell and gene therapies. Federica first joined the pharma industry in 2012 working in basic and applied research and progressively took on regulatory positions of increasing responsibility and leadership as she moved through various pharma companies and CROs. She has supported pre-approval biologics for allergy, oncology, neurology, ophthalmology, dermatology, pediatric and rare disease indications. Federica has experience in developing EU regulatory strategies, leading cross-functional teams in health authority interactions, and in regulatory applications, including document development to support applications such as Scientific Advice, PRIME, Clinical trial Applications (CTA), Orphan Drug Designations (ODD), Pediatric Investigation Plans (PIP), and Development Safety Updated Reports (DSUR). Federica also supports regulatory activities with the FDA, including participating in FDA meetings, Investigational New Drug [IND] applications and amendments, initial Pediatric Study Plans, ODD, and more.
Federica holds a Bachelor of Veterinary Medicine from the University of Camerino in Italy, a Master of Medicine in Research and Development from the University Autonoma of Madrid, and a Ph. D. in Veterinary Pharmacology and Toxicology from the University Complutense of Madrid in Spain.
A highly experienced Senior Leader having achieved a successful career at Director level within the financial services sector, delivering enhanced customer experience and retention through transformational cultural change and innovative digital solutions with commitment to total quality; proven experience of leading, coaching & mentoring diverse operational teams in a complex and regulated environment with international reach, designing and implementing innovative strategies, building key relationships, and influencing at Board level.
